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Abstract There is substantial epidemiological and mech-
anistic evidence that the increase in allergic disease and
asthma in many parts of the world in part relates to chang-
es in microbial exposures and diet acting via the compo-
s i t ion and metabol ic products of the intes t inal
microbiome. The majority of research in this field has
focused on the gut microbiome during infancy, but it is
increasingly clear that the maternal microbiome during
pregnancy also has a key role in preventing an allergy-
prone immune phenotype in the offspring. The mecha-
nisms by which the maternal microbiome influences the
developing fetal immune system include alignment be-
tween the maternal and infant regulatory immune status
and transplacental passage of microbial metabolites and
IgG. Interplay between microbial stimulatory factors such
as lipopolysaccharides and regulatory factors such as
short-chain fatty acids may also influence on fetal im-
mune development. However, our understanding of these
pathways is at an early stage and further mechanistic stud-
ies are needed. There are also no data from human studies
relating the composition and metabolic activity of the ma-
ternal microbiome during pregnancy to the offspring’s
immune status at birth and risk of allergic disease.
Improved knowledge of these pathways may inform novel
strategies for tackling the increase in allergic disorders in
the modern world.
Keywords Maternal . Microbiome . In utero . Immune
programming . Allergy . Asthma
Introduction
The co-evolution of animals and their commensal micro-
organisms has resulted in a symbiosis in which the enteric
microbiome provides essential stimuli for the maturation
and function of the immune system [1]. Accordingly,
there is an intense interest in the relationship between
taxonomic depletion and altered metabolic activity of the
gut microbiome [2–4] and the concordant increase in
immune-related disease in Western societies [2–5]. It is
well recognised that the infant’s microbiome during early
postnatal life plays a central role in healthy immune de-
velopment, but there is also mounting evidence that the
maternal microbiome during pregnancy has a profound
impact on fetal immune development and in turn the in-
fant’s predisposition to allergic disease and asthma. It is a
teleologically appealing proposition to consider the mech-
anisms that may exist to prepare the infant for the micro-
bial and antigenic environment that will be encountered
during and following birth. Does the mother ready the
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developing infant for the specific environment they will
be born into and are the changes in the maternal gut
microbiome during pregnancy [6] relevant to healthy fetal
immune development? The aim of this review is to con-
sider current thinking and evidence regarding the mecha-
nisms by which the maternal gut microbiome during preg-
nancy influences fetal immune development and the po-
tential relevance of these pathways to the prevention of
allergic disease.
Epidemiological evidence linking the maternal
microbiome and allergic disease in the offspring
There is substantial evidence that exposure to a farming envi-
ronment during early life is associated with diverse bacterial
experience and reduced risk of allergic sensitisation and asth-
ma [7]. In the PASTURE study, it was shown that living in a
farming environment was associated with both increased en-
vironmental endotoxin and reduced asthma incidence [8].
Building on this, the PARSIFAL [9] and GABRIELA [10]
studies confirmed that children living on farms had a lower
prevalence of asthma and other atopic disease in comparison
to children from suburban areas, and that this association re-
lated to increased exposure to environmental microorganisms
in farming homes [11]. Further analysis of these studies indi-
cated that the effect on asthma was largely explained by ex-
posure to cows, straw, consumption of raw cow’s milk [12]
and exposure to livestock [13].
Although it seems likely that contemporaneous exposure to
a microbially rich environment prevents the expression of
allergic disease in children [14], maternal exposures during
pregnancy are also likely to be relevant. In PARSIFAL, ma-
ternal exposure to stables during pregnancy was clearly asso-
ciated with decreased allergic sensitisation amongst the off-
spring, whereas current exposure had much weaker effects
[15]. Consistent with this, a large cross-sectional study found
that the protective effect of prenatal livestock exposure on risk
of asthma and hay fever symptoms remained unchanged fol-
lowing adjustment for postnatal exposure, whereas the protec-
tive effect of livestock exposure during the first 2 years of
postnatal life was substantially attenuated by controlling for
prenatal exposure [16]. Of note though, these and other related
epidemiological studies are limited by high levels of correla-
tion between pre- and postnatal microbial exposure, making it
difficult to tease apart the importance of the two periods.
Moreover, environmental exposures provide only a proxy
for the maternal and infant microbiome, and there are current-
ly no published human studies which enable independent
evaluation of the importance of prenatal maternal and postna-
tal infant microbiomes to the prevention of allergic disease.
A range of studies have established clear links between
differences in innate and adaptive immunity at birth and
subsequent allergic disease and asthma, which suggests that
in utero immune development is likely to be relevant to the
prevention of allergy and asthma. In the 1990s, several studies
reported links between decreased IFNg (Th1) responses in
cord blood mononuclear cells and subsequent allergic disease
[17–19]. Subsequent studies have established links between
increased innate immune responsiveness [20, 21], deficits in
regulatory T cell number, function and responsiveness
[21–23] and subsequent allergic outcomes. While there is in-
sufficient evidence to show that the association between mi-
crobial exposure during pregnancy and decreased allergic dis-
ease in the offspring is mediated by these immune parameters
in the newborn, it is clear that infants of mothers exposed to a
farming environment display different innate immune gene
expressions [24] as well as increased number and efficiency
of regulatory T cells [25].
Mechanisms by which the maternal microbiome
during pregnancy may influence fetal immune
development
Alignment between maternal and infant immunity
Alignment between maternal and infant immunity may be one
mechanism linking the maternal microbiome to the offspring’s
risk of allergic disease. There is a substantial body of evidence
supporting transplacental immune regulation during pregnan-
cy. Maternal IgGs loaded with e.g. microbial components
from the mother cross the fetal–maternal barrier by an active
process from 13 weeks gestation [26], conveying temporary
passive immunity [27] and influencing fetal innate immune
development [28]. In contrast, cellular components are gener-
ally separated by the placenta, with some leakage in both
directions without preference toward a specific cell type
[29]. This cellular leakage is functionally important, as mater-
nal cells residing in fetal lymph nodes induce fetal regulatory
T cells that suppress antimaternal immunity [30].
Transplacental immune regulation may be further mediated
by cytokines, hormones [31], through bacterial products such
as short-chain fatty acids [32] or lipopolysaccharides (LPS)
[33, 34].
Santner-Nanan et al. have demonstrated a strong correla-
tion of peripheral blood Treg cells between the mother and the
fetus [35]. In contrast, there was no significant Treg cell corre-
lation between the father and the fetus, implicating that the
specific context of pregnancy, i.e. the placental environment,
rather than haploidentical genetic parental similarity to the
fetus, is responsible for this correlation. Maternal infant align-
ment in Treg cells appeared to be mediated by IL-10, a
pleiotropic cytokine with potent immunoregulatory properties
[36]. Treg cells are characterised by increased expression of the
IL-10 receptor-α (IL-10RA), making them more sensitive to
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the effects of IL-10. The IL-10 regulates Bcl-2 expression in
Treg cells, which could contribute to Treg cell survival in both
the mother and the infant [35].
In the context of alignment between maternal and infant
Treg, it is relevant to consider emerging evidence linking preg-
nancies complicated by preeclampsia with increased risk of
asthma and allergic sensitisation in the offspring [37].
Impaired growth of the fetal thymus precedes the onset of
clinically detectable preeclampsia [38]; and preeclampsia has
been associated with decreased peripheral blood Treg in both
the mother [39] and newborn [40]. One potential shared ante-
cedent is the maternal microbiome and its metabolic products,
including short-chain fatty acids (SCFAs).
Production of SCFAs in the maternal gut
Over recent years, there has been an intense interest in the
relationship between diet, the composition and metabolic
products of the intestinal microbiome and immune-related
disease [41]. In particular, it has been clearly demonstrated
that bacteria in the large intestine ferment dietary fibre to pro-
duce SCFAs, which in turn have a profound influence on a
range of inflammatory diseases [42, 43], Treg biology [44–46],
dendritic cell (DC) biology [42, 47] and/or epithelial integrity
[48, 49]. To date, however, only one study has directly inves-
tigated the relationship between maternally derived SCFAs
and fetal immune programming. Thorburn et al. found that
pregnant mice fed on high-fibre diet or treated with the
SCFA acetate in drinking water during pregnancy had off-
springs protected from allergic airways disease [32]. The ben-
eficial effects of fibre and acetate were mediated in utero as
supplementation during lactation had no effect. These benefi-
cial effects were mediated through epigenetic effects with ac-
etate increasing H4 acetylation in the FoxP3 promoter region,
which correlated with increased Treg numbers in both mothers
and offsprings. High-fibre-fed and acetate-treated pregnant
mice had fetuses with differential gene expression in the lungs
compared to control mice. There are currently no equivalent
data from human studies.
Maternal IgG and fetal innate immune development
Maternal IgG may play a key role in mediating the association
between the maternal microbiome and fetal immune develop-
ment. Of the five immunoglobulin classes, maternal IgG is the
only antibody that significantly crosses the human placenta
[26, 50]. The active transport of IgG occurs via the neonatal
Fc receptor (FcRn) within the syncytiotrophoblast (ST) cells
at the surface of the chorionic villi of the placenta. Once bound
to the FcRn receptor, IgG is packaged in endosomes and
protected from degradation until it dissociates into the fetal
circulation [50, 51].
This materno-fetal IgG transport is an important mecha-
nism that confers passive humoral immunity to the fetus, so
that after birth, the infant is protected against infections while
its own immune system develops [26, 50]. Allergen-specific
maternal IgG also plays a role in the induction of immune
tolerance in infant [52]. Until recently, maternal IgG transfer
during gestation had only been linked to fetal humoral immu-
nity, but there is now good evidence that maternal IgG also
plays a crucial in fetal innate immune development [28].
Aguero et al. colonised pregnant germ-free mice with a genet-
ically engineered Escherichia coli with a limited lifespan,
such that the mothers were germ free again by the time of
birth. Colonisation with E. coli during pregnancy increased
the numbers of innate leukocytes (NKp46 + innate lymphoid
cells (ILC)) within the offspring Peyer’s patches during the
postnatal period. At the same time, maternal carriage of E. coli
was associated with attenuated inflammatory responses
(TNF-α and IL-6) to stimulation with LPS, which may be
relevant to the prevention of the hyperresponsive innate phe-
notype associated with allergic disease in humans [20, 21].
Similar effects in the offspring could be produced if germ-
free dams were infused with serum from E. coli colonised
mothers, but not if the serum was depleted of IgG. Further
to this, maternal antibodies enhanced the retention and trans-
mission of targeted microbial molecules produced by the E.
coli, and these molecules were responsible for the increase in
offspring innate leukocytes [28].
Early exposure to lipopolysaccharide (endotoxin)
producing bacteria
The maternal intestinal microbiome may also confer protec-
tion against allergic disease and asthma in the offspring via
TLR-dependent pathways [34]. Interactions between bacteri-
ally derived LPS (endotoxin) and TLR4 are of particular in-
terest given consistent evidence that associations between mi-
crobial exposures and allergic outcomes in humans are mod-
ified by polymorphisms in the TLR4 gene [53–56]. However,
the relationship between LPS exposure and allergic diseases is
complex, with some epidemiological studies finding that en-
vironments with high levels of endotoxin are associated with
decreased allergic disease [14, 57], while others link endotox-
in exposure to increased allergic disease [58]. This may relate
to diversity amongst LPS molecules in regard to their TLR4
stimulatory capacity [59, 60]. Several different endotoxin iso-
forms have been identified that vary in the extent of acylation
of the TLR4-binding lipid A portion of the molecule. While
the penta-acylated lipid A variant produced by many bacteria
confers a degree of TLR4 inhibition, the hexa- or hepta-
acylated lipid A variants are potent stimulators of TLR4 sig-
nalling, resulting in promotion of T helper type 1 (Th1) re-
sponses [61, 62]. Moreover, immune cells may mount Treg,
Th2 or Th17 responses following exposure to stimulatory
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LPS, depending on the presence of various other immunoreg-
ulatory ligands [63]. Bacterial isolates from farming environ-
ments (cow sheds) have high levels of stimulatory (hexa- or
hepta-acylated lipid A variants) LPS variants [64]. Increased
Treg numbers and suppressive functions in offspring of farm-
ing mothers [25] may reflect an interaction between Th1 driv-
ing stimulators and immunoregulatory mediators. More spe-
cifically, it is an intriguing possibility that the maternal
microbiome may provide immunostimulatory components
such as hexa-acylated LPS, in combination with immunoreg-
ulatory microbial metabolites such as SCFAs, to promote Treg
development and immune tolerance in the developing fetus.
Manipulating the maternal microbiome
during pregnancy to prevent allergic disease
and asthma
Given the increasing evidence that infant gut microbial com-
position plays a pivotal role in the development of immune
responses, probiotic and/or prebiotic supplementation during
pregnancy and infancy has been investigated as an approach
to modify early gut colonisation and prevent allergic diseases.
Probiotics are defined as ‘live microorganisms that, when ad-
ministered in adequate amounts, confer a health benefit on the
host’. The most widely used probiotic bacteria are from the
genus Lactobacillus and Bifidobacteria. Prebiotics are defined
as ‘a selectively fermented ingredient that allows specific
changes, both in the composition and/or activity in the gastro-
intestinal microbiota that confers benefits upon host well be-
ing and health’. The term synbiotic refers to combination of
probiotics and prebiotics.
Recently, high-quality meta-analyses have concluded that
probiotic supplementation, when administered during both the
prenatal and postnatal period, is effective for prevention of
eczema, IgE associated eczema, atopic sensitisation and food
sensitisation, particularly in infants with a family history of
allergic disease [65–67]. There has however been just one
study evaluating probiotic supplementation (with
Lactobacillus rhamnosus GG) during the prenatal period
alone which showed no beneficial effects for prevention of
eczema, IgE associated eczema, atopic sensitisation or food
sensitisation [68]. Meta-analyses of probiotic administration
solely to infants during the postnatal period have yielded con-
flicting results with some finding no beneficial preventive
effects on eczema [69] or increased risk of atopic sensitisation
[66]. These findings suggest that a prenatal component of
treatment is important for beneficial effects, highlighting the
important influence of maternal factors in infant immune pro-
gramming. Most probiotic prevention studies have involved
infants at increased risk of allergic disease due to presence of
allergic disease in a first-degree relative, so it remains uncer-
tain whether probiotic supplementation will be effective in
infants without a family history of allergic disease. The use
of probiotic mixtures appears to be more effective than single
species of either Lactobacillus or Bifidobacteria [65], and
infants delivered by caesarean section may receive greater
benefit from prenatal/postnatal probiotic supplementation that
infants delivered vaginally [66].
Evidence from animal studies clearly shows that maternal
supplementation with prebiotics during pregnancy may re-
duce the features of allergic disease in the offspring. For ex-
ample, in mice, maternal consumption of non-digestible oli-
gosaccharides during pregnancy is associated with decreased
dermatitis [70] and allergic airways disease [32, 71] and in
pigs, as increased Th1 and Treg immunity [72]. However,
while there are a number of related trials in progress, the effi-
cacy of prebiotic supplementation during pregnancy in
humans remains uncertain.
Meta-analyses have found no consistent beneficial effects
from probiotic supplementation (either prenatal, postnatal or
both) for prevention of asthma, rhinoconjunctivitis or food
allergy [65, 67]. Thus, despite promising findings from some
individual studies, it is difficult to recommend routine use of
probiotics for allergy prevention [73]. It is however important
to recognise that probiotic effects are species-specific; conse-
quently, pooling of studies that use different probiotic species
in meta-analyses has been criticised [74]. Indeed, even strains
within one species may have very different biological proper-
ties [75]. Only a small proportion of potentially suitable mi-
crobes have been evaluated. Almost all current probiotics are
Gram-positive, with the exception of the E. coli strain Nissle
[34, 76]. Our understanding of the impact of probiotics on the
overall composition and metabolic activity of the gut
microbiome is very limited. There is much to be learnt about
the multitude of organisms yet to be evaluated as potential
probiotics, including Gram-negative and anaerobic bacteria
and parasites, alone and in combination, as well the impor-
tance of diet-microbiome interactions [77]. This gap in knowl-
edge provides an exciting opportunity for new studies to de-
velop novel and sophisticated strategies for restoring a healthy
microbiome.
Conclusions
A range of epidemiological and mechanistic evidence sup-
ports the contention that the composition and metabolic prod-
ucts of the maternal microbiome play a key role in program-
ming tolerogenic immune phenotypes in the offspring at birth
in turn decreasing the risk of allergic disease and asthma. The
mechanisms involved may include alignment between mater-
nal and infant immunity as well as transplacental passage ma-
ternal IgG and microbial metabolites. There is also an evolv-
ing understanding of the importance of LPS variants and their
interaction with the developing immune system, and the
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metabolite and cytokine milieu in which these interactions
occur. Interplay between a ‘Westernised’ microbiome and
the modern diet may be crucial. At present, however, there is
insufficient evidence to support the implementation of inter-
ventions to manipulate the maternal microbiome during preg-
nancy for prevention of allergic disease and or asthma in the
offspring. Given dramatic advances in our ability to character-
ise the composition and metabolic activity of the microbiome,
studies are required that link direct measures of the maternal
microbiome in humans, with immune phenotypes in the off-
spring and subsequent allergic outcomes. There has been a
vast amount of work done on the infant microbiome, but the
maternal microbiome during pregnancy remains relatively
underinvestigated, particularly in humans, and may be of fun-
damental importance to the prevention of allergic disease and
asthma in the modern environment.
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